基于网络药理学、分子对接和实验验证索罗西汤颗粒预防慢性阻塞性肺疾病的作用及机制研究OA
Study on the mechanism of Srolo Bzhtang in the prevention of chronic obstructive pulmonary disease based on net-work pharmacology,molecular docking and in vivo experiments
目的:基于网络药理学、分子对接与体内实验,首次探讨藏医药经典名方索罗西汤(SBT)颗粒预防慢性阻塞性肺疾病(COPD)的药效与机制.方法:筛选SBT入血成分与COPD疾病靶点交集,构建网络并进行富集分析,采用分子对接验证关键靶点.将大鼠分为空白组、模型组、地塞米松组及SBT低、中、高剂量组,除对照组外采用香烟烟雾联合脂多糖构建COPD大鼠模型.采用预防性给药,地塞米松组(0.2 mg·kg-1)、索罗西汤低剂量组(1.35 g·kg-1)、索罗西汤中剂量组(2.7 g·kg-1)和索罗西汤高剂量组(8.1 g·kg-1),每组10只,每日1次,灌胃给药共60 d,空白组与模型组灌胃等量生理盐水.观察肺组织病理及胶原沉积,检测血清炎症因子(TNF-α、IL-1β、IL-6)及氧化应激指标(MDA、SOD),Western blot检测MAPK与PI3K/AKT通路相关蛋白表达.结果:SBT入血成分与COPD交集靶点125个,关键富集通路包括MAPK与PI3K/Akt.动物实验显示,与模型组比较,SBT各剂量组可降低TNF-α、1L-1β、1L-6水平,提高SOD活性、降低MDA含量,下调肺组织p-PI3K、p-AKT、p-ERK、p-p38及p-JNK蛋白表达.结论:索罗西汤颗粒通过同时调控PI3K/AKT与MAPK信号通路,发挥抗炎与抗氧化应激的双重作用,是其预防COPD的重要机制.
Objective:To preliminarily investigate the pharmacodynamics and mechanism of Tibet medicine classic formula Srolo Bzhtang(SBT)granules in preventing chronic obstructive pulmonary disease(COPD)based on network pharmacology,molecular dock-ing,and in vivo experiments.Methods:The intersection of SBT blood components and COPD disease targets was screened,followed by network construction and enrichment analysis.Key targets were validated using molecular docking.Rats were divided into blank control group,model group,dexamethasone group,and SBT low-,medium-,and high-dose groups.The COPD model was established using cigarette smoke combined with lipopolysaccharide in all groups except the control group.Preventive administration was adopted,with the dexamethasone group(0.2 g·kg-1),SBT low-dose group(1.35 g·kg-1),SBT medium-dose group(2.7 g·kg-1),and SBT high-dose group(8.1 g·kg-1),each consisting of 10 rats.All groups received once-daily intragastric administration for 60 days,while the con-trol group and model group received an equal volume of normal saline.Lung histopathology and collagen deposition were observed.Se-rum levels of inflammatory factors(TNF-α,IL-iβ and IL-6)and oxidative stress markers(MDA and SOD)were measured.Expression of MAPK and PI3K/Akt pathway-related proteins was detected by Western blot.Results:A total of 125 intersecting targets were identi-fied between SBT blood components and COPD,with key enrichment pathways including MAPK and PI3K-Akt.Animal experiments showed that compared with the model group,each SBT dose group reduced TNF-α、1L-1β、1L-6 levels,increased SOD activity,de-creased MDA content,and downregulated the protein expression of p-ERK,p-PI3K,p-AKT,p-p38,and p-JNK in lung tis-sue.Conclusion:SBT granules exert anti-inflammatory and anti-oxidative stress effects by simultaneously regulating the PI3K/AKT and MAPK signaling pathways,representing a key mecha-nism in its prevention of COPD.
张琳枝;旦增央金;色珍;边巴顿珠;贡布;边巴次仁;叶本贵
西藏大学医学院,西藏拉萨 850000西藏自治区藏医院(西藏自治区藏医药研究院),西藏拉萨 850001西藏自治区藏医院(西藏自治区藏医药研究院),西藏拉萨 850001西藏自治区藏医院(西藏自治区藏医药研究院),西藏拉萨 850001西藏自治区藏医院(西藏自治区藏医药研究院),西藏拉萨 850001西藏自治区藏医院(西藏自治区藏医药研究院),西藏拉萨 850001西藏大学医学院,西藏拉萨 850000||四川大学华西药学院,四川成都 610041
医药卫生
索罗西汤网络药理学分子对接COPDPI3K-AKTMAPK
Srolo Bzhtangnetwork pharmacologymo-lecular dockingCOPDPI3K/AKTMAPK
《中药与临床》 2026 (4)
35-43,中插10-中插11,11
2023年中央对地方转移支付资金(中医药事业传承与发展)重点支持项目子项目中药创新能力提升项目2023年西藏自治区科技计划"揭榜挂帅"项目(XZ2023ZY0007G)
评论